- Patent Title: Treatment of short bowel syndrome patients with colon-in-continuity
-
Application No.: US15285855Application Date: 2016-10-05
-
Publication No.: US09968655B2Publication Date: 2018-05-15
- Inventor: Elizabeth L. Sanguinetti , Thomas B. Marriott , Jennifer Lopansri , Consuelo M. Blosch
- Applicant: Shire-NPS Pharmaceuticals, Inc.
- Applicant Address: US MA Lexington
- Assignee: Shire-NPS Pharmaceuticals, Inc.
- Current Assignee: Shire-NPS Pharmaceuticals, Inc.
- Current Assignee Address: US MA Lexington
- Agency: Troutman Sanders LLP
- Main IPC: A61K38/16
- IPC: A61K38/16 ; A61K38/26 ; A61K9/00
Abstract:
Intestinal absorption is enhanced in short bowel syndrome patients presenting with colon-in-continuity by treatment with a GLP-2 receptor agonist, such as teduglutide.
Public/Granted literature
- US09597373B2 Treatment of short bowel syndrome patients with colon-in-continuity Public/Granted day:2017-03-21
Information query
IPC分类:
